AVITA Medical, Inc.RCELNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P21
Within normal range
vs 3Y Ago
-0.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-12.56%
202439.26%
202345.05%
202221.58%
20210.41%
2020-23.95%
201976.26%
201830.33%
201752.59%
201627.18%